Dicerna Pharmaceuticals
DRNA
#4014
Rank
NZ$5.43 B
Marketcap
NZ$69.76
Share price
0.00%
Change (1 day)
17,701.60%
Change (1 year)

Market capitalization of Dicerna Pharmaceuticals (DRNA)

Last known market cap: NZ$5.43 Billion

As of November 2026 Dicerna Pharmaceuticals has a market cap of NZ$5.43 Billion. This makes Dicerna Pharmaceuticals the world's 4014th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Dicerna Pharmaceuticals from 2014 to 2022

End of year Market Cap

Year Marketcap Change
2022NZ$4.69 B7.58%
2021NZ$4.35 B88.48%
2020NZ$2.31 B-1.2%
2019NZ$2.34 B115.37%
2018NZ$1.08 B65.56%
2017NZ$0.65 B660.98%
2016NZ$86.28 M-75.84%
2015NZ$0.35 B-4.47%
2014NZ$0.37 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
NZ$285.03 B 5,144.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$430.07 B 7,813.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$601.64 B 10,970.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
NZ$1.03 B-81.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$35.15 B 546.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
NZ$10.67 B 96.41%๐Ÿ‡บ๐Ÿ‡ธ USA